共 50 条
- [43] Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma Journal of Gastrointestinal Surgery, 2016, 20 : 1541 - 1546
- [45] Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (06): : 1943 - 1950
- [47] Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis Annals of Surgical Oncology, 2023, 30 : 7461 - 7471
- [49] Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (04):